Here's our regular rundown of new and notable veterinary products.
Anivive Lifesciences' Chief Commerical Officer Chad Todd, DVM, discussed the future of Anivive Lifesciences including the development of a new vaccine.
CYCLAVANCE™ oral solution marks the first FDA-approved liquid cyclosporine for dogs in the United States.
The pet biotechnology company is looking to collaborate with veterinary clinics to help advance its research studies focusing on areas of unmet needs in feline health.
The CBD line was created with the respect for the intensity, agility, and endurance canine athletes and working dogs experience.